Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells
Life · 15.06.2023 · 13 (6) · 1397
DOI: 10.3390/life13061397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 15.06.2023. Verfasst von Sabine Wächter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Baldigerstrasse, 35043 Marburg, Germany. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIT Research Grant Philipps University Marburg, MIT Research Grant from the Philipps University Marburg, Open-Access-Publikationsfonds of the Philipps University Marburg.
Abstract (Originalsprache)
Radiotherapy and immunotherapy have shown promising efficacy for the treatment of solid malignancies. Here, we aim to clarify the potential of a combined application of radiotherapy and programmed cell death-ligand 1 (PD-L1) monoclonal antibody atezolizumab in primary anaplastic thyroid cancer (ATC) cells. The radiation caused a significant reduction in cell proliferation, measured by luminescence, and of the number of colonies. The addition of atezolizumab caused a further reduction in cell proliferation of the irradiated ATC cells. However, the combined treatment did not cause either the exposure of the phosphatidylserine or the necrosis, assessed by luminescence/fluorescence. Additionally, a reduction in both uncleaved and cleaved forms of caspases 8 and 3 proteins was detectable in radiated cells. The DNA damage evidenced the over-expression of TP53, CDKN1A and CDKN1B transcripts detected by RT-qPCR and the increase in the protein level of P-γH2AX and the DNA repair deputed kinases. PD-L1 protein level increased in ATC cells after radiation. Radiotherapy caused the reduction in cell viability and an increase of PD-L1-expression, but not apoptotic cell death in ATC cells. The further combination with the immunotherapeutic atezolizumab could increase the efficacy of radiotherapy in terms of reduction in cell proliferation. Further analysis of the involvement of alternative cell death mechanisms is necessary to clarify their cell demise mechanism of action. Their efficacy represents a promising therapy for patients affected by ATC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Baldigerstrasse, 35043 Marburg, Germany.
- Department of Radiotherapy and Radio Oncology, Philipps University Marburg, Baldigerstrasse, 35043 Marburg, Germany.
- Laboratory of Radiobiology & Experimental Radiooncology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
ORCID-Profile: Sabine Wächter, Ulrike Schötz, Rita Engenhart-Cabillic, Elisabeth Maurer, Pietro Di Fazio
Förderung
- MIT Research Grant Philipps University Marburg
- MIT Research Grant from the Philipps University Marburg
- Open-Access-Publikationsfonds of the Philipps University Marburg
Zitieren
APA
Wächter, S., Roth, S., Gercke, N., Schötz, U., Dikomey, E., Engenhart-Cabillic, R., Maurer, E., Bartsch, D. K., & Di Fazio, P. (2023). Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells. Life, 13(6), 1397. https://doi.org/10.3390/life13061397
Vancouver
Wächter S, Roth S, Gercke N, Schötz U, Dikomey E, Engenhart-Cabillic R, et al. Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells. Life. 2023;13(6):1397. doi:10.3390/life13061397
BibTeX
@article{Wchter2023,
author = {Wächter, Sabine and Roth, Silvia and Gercke, Norman and Schötz, Ulrike and Dikomey, Ekkehard and Engenhart-Cabillic, Rita and Maurer, Elisabeth and Bartsch, Detlef K and Di Fazio, Pietro},
title = {Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells},
journal = {Life},
year = {2023},
volume = {13},
number = {6},
pages = {1397},
doi = {10.3390/life13061397}
}
EUVIMED